NCT07003789

Brief Summary

The WISE Woman Study is a research project in Ghana focused on improving HIV prevention among young women aged 18 to 35. In Ghana, young women are at higher risk of HIV but often lack access to the right information and services. This study will first work with young women and community partners to co-develop a youth-friendly and women-centered HIV prevention program. The program will focus on two proven strategies: HIV self-testing (HIVST) and pre-exposure prophylaxis (PrEP), a medicine that helps prevent HIV. After the program is created, researchers will test it with 50 young women in Greater Accra and the Eastern Region to see if it's acceptable, easy to use, and if it helps increase knowledge and use of HIVST and PrEP. The intervention will be delivered through WhatsApp and community-based workshops to ensure privacy and reach. Participants will complete surveys and take part in discussions and interviews to share their feedback. This research will help build better HIV prevention strategies tailored to the needs of young women in Ghana.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Jul 2025Dec 2026

First Submitted

Initial submission to the registry

May 12, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.5 years

First QC Date

May 12, 2025

Last Update Submit

January 23, 2026

Conditions

Keywords

HIV self-testing (HIVST)Pre-exposure prophylaxis (PrEP)Youth-centered designSub-Saharan AfricaAGYW (Adolescent Girls and Young Women)HIV StigmaGhana

Outcome Measures

Primary Outcomes (5)

  • Feasibility as Measured by FIM Score

    Feasibility of the intervention will be measured using the Feasibility of Intervention Measure (FIM), a validated 4-item scale. Each item is rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Scores will be summarized using means and standard deviations. Higher scores indicate greater feasibility. Unit of Measure: Mean FIM score (1-5 scale)

    Week 5 (end of intervention)

  • Acceptability as Measured by AIM Score

    Acceptability of the intervention will be measured using the Acceptability of Intervention Measure (AIM), a validated 4-item scale with 5-point Likert responses. Scores range from 1 (completely disagree) to 5 (completely agree). Higher scores indicate greater acceptability. Results will be reported as mean and standard deviation. Unit of Measure: Mean AIM score (1-5 scale)

    Week 5 (post-intervention)

  • Uptake of HIV self-testing (HIVST)

    Defined as the number of participants who report completing an HIV self-test during the study period, verified via WhatsApp photo confirmation or verbal report. Unit of Measure: Number of participants (count)

    Baseline to Week 8

  • Willingness to Use PrEP (Survey-Based Behavioral Intention)

    Willingness will be measured using a validated PrEP intention scale in pre- and post-surveys (e.g., "I am likely to take PrEP in the next 3 months"). Items are scored on a 1 to 5 Likert scale, with higher scores indicating greater willingness to use PrEP. Change in mean intention scores will be reported. Unit of Measure: Mean change in score (1-5 scale)

    Baseline to Week 8

  • Intervention Completion Rate

    Defined as the percentage of participants who complete all required activities during the 4-week WhatsApp-based intervention, including pre- and post-surveys. Unit of Measure: Percentage of participants (%)

    Week 5

Secondary Outcomes (3)

  • Reduction in HIV-Related Stigma (Survey Score Change)

    Baseline to Week 8

  • Number of Participants Reporting the WhatsApp-Based Intervention is Sustainable and Scalable

    Week 6-8 (exit interviews)

  • Perceived Appropriateness of the Intervention (IAM Score)

    Week 5

Study Arms (1)

Women-Centered HIV Prevention Group

EXPERIMENTAL

Participants will take part in a co-developed HIV prevention intervention created through participatory workshops. The intervention will be delivered via WhatsApp over 4 weeks and will include HIV prevention messaging, discussion prompts, and peer support to improve awareness and uptake of HIV self-testing (HIVST) and pre-exposure prophylaxis (PrEP), and reduce stigma.

Behavioral: Women-Centered HIV Prevention Program

Interventions

This behavioral intervention consists of a participatory, youth-designed HIV prevention program that uses Human-Centered Design (HCD) principles and WhatsApp-based engagement. It includes information and support for HIV self-testing and PrEP, with the goal of increasing awareness, improving uptake, and reducing stigma among young women in Ghana.

Women-Centered HIV Prevention Group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Identify as female and be between 18-35 years of age
  • Reside in Greater Accra or the Eastern Region of Ghana
  • Be sexually active (defined as having engaged in vaginal, anal, or oral sex in the past 6 months)
  • Have access to a mobile phone with WhatsApp
  • Be willing to provide informed consent
  • Be interested in participating in HIV prevention activities
  • Be comfortable discussing sexual and reproductive health in a group setting (for the workshop)
  • For pilot phase only: must not have participated in the co-development workshop

You may not qualify if:

  • Do not reside in the two specified regions of Ghana
  • Unable to provide informed consent
  • Have cognitive impairments or severe mental health conditions limiting participation
  • Community partners with commercial conflicts of interest (for workshop only)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EARC

Accra, Ghana

Location

MeSH Terms

Conditions

Coitus

Condition Hierarchy (Ancestors)

Sexual BehaviorBehavior

Study Officials

  • Gloria A Aidoo-Frimpong, PhD, MPH, MA

    SUNY BUFFALO

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No masking is used in this study. All participants and study staff are aware of the intervention.
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: A mixed-methods, community-based participatory intervention. Participants co-develop the HIV prevention program and then pilot test it through WhatsApp-based activities.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 12, 2025

First Posted

June 4, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Due to the sensitive nature of the data related to HIV status, stigma, and participant privacy-especially within a small, community-based sample-individual participant data (IPD) will not be shared to protect confidentiality.

Locations